NCT07108439

Brief Summary

The investigators are doing a study to see if a new way of giving local anesthesia during dental surgery can help children feel better after having a tooth removed under general anesthesia (when they are fully asleep). Normally, dentists give numbing medicine that can leave the lips or cheeks numb. This sometimes causes children to bite themselves without realizing it, which can make them upset when they wake up. In this study, the investigators are testing a special technique called intra-osseous anesthesia, which numbs only the tooth and not the surrounding soft tissues. The investigators hope this will reduce pain after surgery without causing numbness or accidental biting. Children in the study will be randomly placed into one of two groups: one group will receive this special anesthesia before the tooth is removed, and the other group will not. Before and after the procedure, the investigators will ask some short questions and observe the participants to check for pain, anxiety, or confusion. The parents of the participants will also receive a short online questionnaire to fill out the day after the procedure. The goal is to find out if this method helps children wake up more comfortably, feel less pain, and avoid side effects. This could improve how dentists care for children during dental treatments in the future.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
11mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Aug 2025May 2027

First Submitted

Initial submission to the registry

July 8, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 7, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

August 14, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2027

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2027

Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1.7 years

First QC Date

July 8, 2025

Last Update Submit

September 29, 2025

Conditions

Keywords

Intra-osseous anesthesiapain management

Outcome Measures

Primary Outcomes (4)

  • postoperative delirium in the child (flowchart)

    to investigate whether the administration of intra-osseous local anaesthesia (Quicksleeper 5, an electronically controlled intra-osseous anaesthesia injection system) to children during general anaesthesia prior to the extraction of a first permanent molar (FPM) has an effect on immediate and later postoperative delirium in the child. Postoperative delirium will be assessed 5 min after spontaneous eye opening using a validated flowchart

    5 minutes after spontaneous eye opening

  • Pre- and postoperative pain in the child (Visual Analogue Scale - VAS)

    to investigate whether the administration of intra-osseous local anaesthesia (Quicksleeper 5, an electronically controlled intra-osseous anaesthesia injection system) to children during general anaesthesia prior to the extraction of a first permanent molar (FPM) has an effect on immediate and later postoperative pain in the child. Pre-and postoperative pain will be assessed at a fixed time after the procedure (after 120 minutes) using the validated VAS (Visual Analogue Scale) scale. Upon arrival at the hospital, the preoperative VAS will be taken. The scale consists of a line of numbers from 0 (left side of the line) to 10 (right side of the line). The higher the number, the more pain, so a worse outcome.

    Preoperative: upon arrival at the hospital Postoperative: after 120 minutes

  • Pre- and postoperative pain in the child (Face-Legs-Activity-Cry-Consolability Scale)

    to investigate whether the administration of intra-osseous local anaesthesia (Quicksleeper 5, an electronically controlled intra-osseous anaesthesia injection system) to children during general anaesthesia prior to the extraction of a first permanent molar (FPM) has an effect on immediate and later postoperative pain in the child. Pre-and postoperative pain will be assessed at fixed times after the procedure (after 10/30/60/120 minutes) using the validated FLACC (Face-Legs-Activity-Cry-Consolability Scale) scales. Upon arrival at the hospital, the preoperative FLACC will be taken. The scale consists of 5 scores assigned by an observer based on child's behavior/attitude. The sum of these determines the pain. 0 is no pain, 10 is intense pain. The higher the score, the outcome is worse.

    Preoperative: arrival at the hospital, postoperative: after 10,30,60,120 minutes

  • Pre- and postoperative anxiety in the child (CFSS-DS - Children's Fear Survey Schedule - Dental Subscale)

    to investigate whether the administration of intra-osseous local anaesthesia (Quicksleeper 5, an electronically controlled intra-osseous anaesthesia injection system) to children during general anaesthesia prior to the extraction of a first permanent molar (FPM) has an effect on immediate and later postoperative anxiety in the child. Postoperative anxiety will be assessed at a fixed time after the procedure (after 120 minutes) using a validated scale (CFSS-DS - Children's Fear Survey Schedule - Dental Subscale). The scale consists of 15 questions with a score from 1 till 5. A score of 15 in total means no anxiety, a higher score means more dental anxiety/fear, so a worse outcome.

    Preoperative: upon arrival at the hospital Postoperative: after 120 minutes

Secondary Outcomes (1)

  • presence of postoperative side effects related to local anesthesia

    10 minutes up to 24 hours 10, 30, 60, 120 minutes after waking up (VAS - Visual Analogue Scale, FLACC - Face, Legs, Activity, Cry and Consolability, CFSS-DS- Children's Fear Survey Schedule - Dental Subscale questionnaire). After 24 hours: QoR-15

Other Outcomes (1)

  • Possible influence of the child's gender, site of extraction (maxilla or mandible/left or right)

    up to 24 hours

Study Arms (2)

intra osseous administration of local anesthesia during general anesthesia

EXPERIMENTAL

Intra osseous administration of articain 4% 1/100 000 during general anesthesia for the extraction of a first permanent molar. The administration will be done with Quicksleeper 5.

Other: Administration of intra-osseous local anesthesia before the extraction of a first permanent molar under general anesthesia

Control group

NO INTERVENTION

Normal procedure: no local anesthesia for the extraction of a first permanent molar during general anesthesia

Interventions

Intra osseous administration of articain 4% 1/100 000 during general anesthesia for the extraction of a first permanent molar. The administration will be done with Quicksleeper 5.

intra osseous administration of local anesthesia during general anesthesia

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \- Children between 6 and 12 years old, belonging to the category of ASA I or II according to the 'American Society of Anaesthesiologists'
  • Children who are cooperative enough for pre- and post-operative measurements
  • Children who are not allergic to components of local anaesthesia
  • Children who need at least one extraction of a FPM
  • Children without a hematological condition
  • Children who haven't taken painkillers 48 hours before the procedure
  • Patients who need a treatment under general anaesthesia (nasal intubation) due to polycaries/fear/anxiety.
  • Able to obtain a written consent from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes

You may not qualify if:

  • \- Treatment with a laryngeal mask
  • If a traumatic extraction is needed, this patient is excluded from the study
  • Deviation in the pain relief protocol
  • Parents/child don't speak Dutch
  • Patients with missing data during the procedure/follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University Hospital

Ghent, 9000, Belgium

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Chloë Sterkens

    Equal Lifelong Oral Health for All Research Group, Paediatric Dentistry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sivaprakash Rajasekharan, BDS,MSc,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Blinding is performed using a 6 digit code generated randomly using www.random.org. This code shall be used in all the patients files and shall only be known to the trial administrator. It is a double blind study in which the operator knows whether she is giving intra-osseus anesthesia (articaine) or not, but the patient and the evaluator of the pre- and post- operative scales will not know if the patient got local anaesthesia or not. SR has the excel file with the results of the block randomisation and key for blinding (pseudonymization). Allocation concealment will be performed by with the sealed envelope technique.SR is independent of the study results. He has no access to the results of the patients.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2025

First Posted

August 7, 2025

Study Start

August 14, 2025

Primary Completion (Estimated)

May 5, 2027

Study Completion (Estimated)

May 6, 2027

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The IPD must be shared as anonymized or pseudonymized information. Data transfer must be conducted under Ghent University Hospital conditions, with legal experts drafting and reviewing the agreement (https://hiruz.be/cu/). Additionally, any data containing personal information requires approval from the Ethics Committee before transfer.

Locations